SBIR-STTR Award

High throughput screening for splice variant cDNAs
Award last edited on: 6/30/08

Sponsored Program
SBIR
Awarding Agency
NIH : NHGP
Total Award Amount
$781,371
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Jeanmichel A Lelias

Company Information

Genofi LLC

1030 Calle Cordillera Suite 107
San Clemente, CA 92673
   (949) 388-2787
   info@genofi.com
   www.genofi.com
Location: Single
Congr. District: 49
County: Orange

Phase I

Contract Number: 1R43HG003658-01A1
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2006
Phase I Amount
$100,000
The catalog of human splice variant mRNAs is believed to be far from complete with many undiscovered isoforms likely to play an important role in health and disease. The current practice of hunting for splice variants by screening cDNA libraries one at a time is both time consuming and expensive. Higher throughput and more cost-effective methods of screening would be helpful in accelerating this important enterprise. The goal of this proposed work is to develop a consumable research tool that enables rapid and cost- effective screening for splice variant cDNAs. The Library Sampler will be comprised of 15 high-quality cDNA libraries representing 28 human cancer cell lines and 34 human tissues. To evaluate the utility of the Library Sampler, it will be screened by PCR for the known splice variants of 10 genes implicated in various cancers. It is expected that full-length clones representing 70-80% of known isoforms will be identified along with clones representing many novel isoforms. In Phase II, the Library Sampler will be optimized, product application data generated, and a large-scale manufacturing process developed. Relevance to public health: In October 2004 the International Human Genome Sequencing Consortium reduced the estimated number of human protein-coding genes to only 20,000-25,000 genes, a surprisingly low number for our species, suggesting that gene regulation is far more important than gene number. It is well known that most of our genes produce more than one protein by alternative splicing of the primary transcript of the gene but the indentification of all these isoforms is far from complete. The Library Sampler provides a powerful research tool to identify these splice isoforms from a broad range of normal tissues and cancer cell lines, and because many splice isoforms have been associated with human genetic diseases, their discovery offers new potentials for the development of clinical biomarkers and molecular diagnostic testing

Phase II

Contract Number: 2R44HG003658-02
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2007
(last award dollars: 2008)
Phase II Amount
$681,371

The catalog of human splice variant mRNAs is believed to be far from complete with many undiscovered isoforms likely to play an important role in health and disease. The current practice of hunting for splice variants by screening cDNA libraries one at a time is both time consuming and expensive. Higher throughput and more cost-effective methods of screening would be helpful in accelerating this important enterprise. The aim of this project is to create a valuable research tool for the rapid identification of alternative splice isoforms. The Library Sampler described in this proposal represents a collection of high-quality cDNA libraries organized in two panels of 384 low-complexity pools that can be used to identify splice variants, polymorphisms and mutants from a broad range of normal tissues, tumors and cancer cell lines. The main advantage of this proposed work is to allow a simple PCR approach to efficiently screen a large diversity of human sources represented by over 9 million cDNA clones. Due to the low complexity of the cDNA pools the PCR products can be sequenced directly and used in sub-cloning experiments, giving the researcher an immediate answer on a set of mRNA isoforms corresponding to the gene of interest. A graphical web interface will be developed using a comprehensive eukaryotic splice variant database to assist scientists with their experimental design, and a set of novel splice isoforms from a list of selected genes will be identified to demonstrate the value of this new discovery tool. The Library Sampler will provide the researcher community with a powerful system to quickly identify all variant transcripts expressed from a single gene. Cataloging all the mRNA isoforms will be fundamental for understanding the complexity of the human proteome, and since many of these variants have been associated with genetic diseases, their discovery will offer new potentials for drug development and molecular diagnostics. In October 2004 the International Human Genome Sequencing Consortium reduced the estimated number of human protein-coding genes to only 20,000 to 25,000 genes, a surprisingly low number for our species, suggesting that gene regulation is far more important than gene number. It is well known that most of our genes produce more than one protein by alternative splicing of their primary transcript, but the identification of all these splice variant forms is far from complete. The proposed Library Sampler provides a powerful research tool to rapidly identify these splice isoforms from a broad range of normal tissues, tumors and cancer cell lines, and because many splice isoforms have been associated with human genetic diseases, their discovery will offer new potentials for drug development and molecular diagnostics